Zepbound phase 3 trials
The central clinical idea: when mitochondrial ATP production falls and oxidative stress rises, the brain may lose the energy and antioxidant reserve needed to regulate neurotransmission, maintain cell membranes, recycle methionine, produce SAM, clear adenosine and homocysteine, build glutathione and tolerate medications or supplements
Using propensity-score matched analysis results showed that who were treated with a GLP-1 receptor agonist at 1 year VTE rates were 20% lower when compared to patients on a DDP-4 inhibitor
Small molecule absorption by PDMS in the context of drug response bioassays
Speight J
It is never appropriate to compare across studies due to different doses, different study designs, different patient groups and other confounding factors, but in the table and figures below are comparisons of the dual agonist LY3298176, Trulicity (dulaglutide), Ozempic (semaglutide) and oral semaglutide